Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Professor John Kane discusses the often-asked question, who is the ideal candidate for long-acting antipsychotic treatment? Sign up for Progress in Mind Middle East and Africa Sign up for our newsletter and stay updated on new content and resources. Related Depression Article Does glutamate hold the key to unlocking major depressive disorder? Schizophrenia Article COVID-19: Pandemic brings challenge and opportunity for people with schizophrenia (including telemedicine!) Depression Schizophrenia Article ICD-11 – fielding for diagnostic success